Jack Mlabasati

Gastroenterology and Hepatology, Alum of @Northwellhealth GI and @BIDMC_IM @harvardmed (RT/likes ≠ endorsement)

[Niranjani Jyotibasu Padayachi MD, MPH @NiranjaniVenka1]

Happy graduation!! Thankful to all my mentors who supported me since medical school!!

Grateful for my co fellows :) @JMlabasati @sandychan @dianalech
#gastroenterologyhepatology #poopdocs

[Jack Mlabasati @JMlabasati]

Incredibly grateful to be have Dr. Hass as a mentor through the ACG! #ACG2024 @AmCollegeGastro

[Jack Mlabasati @JMlabasati]

@tony_breu Do you still use this class of medications in patients with polycythemia vera?

[Jack Mlabasati @JMlabasati]

Another tool in the armamentarium. Curious to see how this medication compares to Ozanimod in the long term #EBGI #GItwitter

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

1/⏰ for #EBGI Tweetorial🧵w/ @FnuVikash

“Etrasimod, a Sphingosine 1-Phosphate Receptor Modulator, for Moderate-Severe Ulcerative Colitis: New Options for Oral Therapy”

📜Summary: https://t.co/ZWdfgS4yF2
🎧https://t.co/RgVd964liY
📰https://t.co/CXg6hapGux @TheLancet

#GITwitter

[Jack Mlabasati @JMlabasati]

Important to inform your patients of these potential side effects prior to side effects prior to starting GLP-1 #EGBI

[Anoushka Dua, MD @anoushkaduaMD]

@ACG_EBGI @jalpa_devi @JAMA_current @AmCollegeGastro 4/ 🔎Findings
Incidence rates of:
-Pancreatitis🔥
-Bowel obstruction🤢
-Gastroparesis🐢
were significantly ⬆️ among users of GLP-1 RAs💉

[Jack Mlabasati @JMlabasati]

It was great being part of this amazing group over the past year. Really an amazing opportunity, would encourage everyone to apply ! #EGBI

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

8 wonderful @ACG_EBGI ambassadors are stepping down this year. Let's give them an outstanding round of 👏 Together, they created amazing #GITwitter evidence-based content & learned a lot along the way!

Now it's your turn😀

Submission deadline Dec 30.
🔗https://t.co/4fdfHQpniJ

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

8 wonderful @ACG_EBGI ambassadors are stepping down this year. Let's give them an outstanding round of 👏 Together, they created amazing #GITwitter evidence-based content & learned a lot along the way!

Now it's your turn😀

Submission deadline Dec 30.
🔗https://t.co/4fdfHQpniJ

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

1/#EBGI Tweetorial🧵w/ @hannahwfiske & @jmlabasati

"ICYMI: Biosimilar BI 695501 Has Similar Safety and Efficacy to Adalimumab for the Treatment of Crohn’s Disease: VOLTAIRE-CD Study"

📜https://t.co/ozmzx0d6kC
🎧https://t.co/Kj6lZmPhEQ
📰https://t.co/5NGgLEggtm @LancetGastroHep

[Jack Mlabasati @JMlabasati]

@ACG_EBGI @AGA_CGH @PhilipOkaforMD @LindaNguyenMD @EBGIdoc @Stanford_GI @JBousaba @JHepatolog @AmCollegeGastro @BilalMohammadMD @ANMSociety @KewinSiah @gastrogirl @LinChangMD @guillaume_md @MayoClinicGIHep @drsusankais @MJWhitsonMD @NiranjaniVenka1 @yuyingMD @SChablaney @DrGaryFalk @vmukkada @KMonkemuller @DCharabaty @TheGastrologer @stevenbollipo @CarlKayMD @noorannemd @JosephHabibi_MD @IrisWangMD @Stentingwoman @TrieuMD @MN_GIMD @john_damianosMD @DVinsard @AbelJosephMD @ALOliphant @gilkaplan @MouhandMD @AlexaWeingarden @AdjoaGIMD @podimuwa @LumirKunovsky @RashidLui 9/Thank you & please check out @ACG_EBGI summaries @ https://t.co/Is37afpX8J

🗓️Stay tuned for next week's tweetorial with @MaryambhaiderMD!
''American College of Physicians Guidance Statement on Colorectal Cancer Screening: Pitfalls of Second-Guessing Guidelines''

[Jack Mlabasati @JMlabasati]

@ACG_EBGI @AGA_CGH @PhilipOkaforMD @LindaNguyenMD @EBGIdoc @Stanford_GI @JBousaba @JHepatolog @AmCollegeGastro @BilalMohammadMD @ANMSociety @KewinSiah @gastrogirl @LinChangMD @guillaume_md @MayoClinicGIHep @drsusankais @MJWhitsonMD @NiranjaniVenka1 @yuyingMD @SChablaney @DrGaryFalk @vmukkada @KMonkemuller @DCharabaty @TheGastrologer @stevenbollipo @CarlKayMD @noorannemd @JosephHabibi_MD @IrisWangMD @Stentingwoman @TrieuMD @MN_GIMD @john_damianosMD @DVinsard @AbelJosephMD @ALOliphant 8/⚠️Caution
👉Single 🏥 Study (limiting generalizability) with small 👥size
👉Most participants in the study (73%) had idiopathic gastroparesis.
👉Short term study duration, need long term ⌛data

[Jack Mlabasati @JMlabasati]

@MJWhitsonMD does this study change how you approach the elimination diet in patients with EoE? #EBGI

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

1/#EBGI Tweetorial🧵w/ @hannahwfiske & @jassimransingh9!
Cooking Up Something New W/ 1⃣-Food Elimination Diet:Simpler Approach to Dietary Tx for Eosinophilic Esophagitis(EoE)
📜Summary https://t.co/fedj73ZYFf
🎧https://t.co/HfKFISqIf4
📰@LancetGastroHep https://t.co/nrsAMlm00u

[Jack Mlabasati @JMlabasati]

@ACG_EBGI @clivejmiranda @DevikaGandhiMD @EBGIdoc @AmJGastro @AdvaniRashmiMD @AmCollegeGastro @stevenbollipo @DCharabaty @IrisWangMD @UmaMahadevanIBD @Stentingwoman @drkeithsiau @TrieuMD @MN_GIMD An easy evidenced based recommendation to provide for patients struggling with constipation #EBGI

[Jack Mlabasati @JMlabasati]

@notthewongrx @BIDMCPharmRes Congrats!

[Jack Mlabasati @JMlabasati]

Great job by @clivejmiranda summarising and important study. Important to always have SBP on your ddx and to treat promptly!

[Evidence-Based GI: An ACG Publication (EBGI) @ACG_EBGI]

⏰ for #EBGI Tweetorial🧵w/ @MItaniMD & @clivejmiranda!

Cephalosporins and Ciprofloxacin Still Appropriate First-Line Treatment for Spontaneous Bacterial Peritonitis

📜Summary https://t.co/TJ5aB2igMP @EBGIdoc
🎧 https://t.co/7UdksZ59Jc
📰 in @AmJGastro https://t.co/9flOq33rnW